Trends in Alzheimer Imaging & Management
In this discussion, Dr Tanenbaum and Suzie Bash, MD, a Medical Director at RadNet in Los Angeles, cover the intersection of disease-modifying therapies (DMTs), quantitative imaging, and artificial intelligence (AI) in managing Alzheimer disease.
5 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Trends in Alzheimer Imaging & Management community!